Laparoscopic versus Open Total Gastrectomy for Locally Advanced Gastric Cancer: Short and Long-Term Results

被引:11
作者
Di Carlo, Sara [1 ]
Siragusa, Leandro [1 ]
Fassari, Alessia [2 ]
Fiori, Enrico [2 ]
La Rovere, Francesca [2 ]
Izzo, Paolo [2 ]
Usai, Valeria [1 ]
Cavallaro, Giuseppe [2 ]
Franceschilli, Marzia [1 ]
Dhimolea, Sirvjo [1 ]
Sibio, Simone [2 ]
机构
[1] Univ Roma Tor Vergata, Dept Surg Sci, Viale Oxford 81, I-00133 Rome, Italy
[2] Sapienza Univ Rome, Dept Surg Pietro Valdoni, Umberto I Univ Hosp, Viale Policlin 155, I-00161 Rome, Italy
关键词
gastric cancer; laparoscopic gastrectomy; open gastrectomy; D2; lymphadenectomy; OPEN DISTAL GASTRECTOMY; RANDOMIZED-CONTROLLED-TRIALS; ASSISTED GASTRECTOMY; RADICAL GASTRECTOMY; ONCOLOGIC OUTCOMES; CROHNS-DISEASE; FEASIBILITY; MULTICENTER; DISSECTION; SURVIVAL;
D O I
10.3390/curroncol29110665
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Laparoscopic gastrectomy for early gastric cancer is widely accepted and routinely performed. However, it is still debated whether the laparoscopic approach is a valid alternative to open gastrectomy in advanced gastric cancer (AGC). The aim of this study is to compare short-and long-term outcomes of laparoscopic (LG) and open (OG) total gastrectomy with D2 lymphadenectomy in patients with AGC. Methods: A retrospective comparative study was conducted on patients who underwent LG and OG for ACG between January 2015 and December 2021. Primary endpoints were the following: recurrence rate, 3-year disease-free survival, 3-year and 5-year overall survival. Univariate and multivariate analysis was conducted to compare variables influencing outcomes and survival. Results: Ninety-two patients included: fifty-three OG and thirty-nine LG. No difference in morbidity and mortality. LG was associated with lower recurrence rates (OG 22.6% versus LG 12.8%, p = 0.048). No differences in 3-year and 5-year overall survival; 3-year disease-free survival was improved in the LG group on the univariate analysis but not after the multivariate one. LG was associated with longer operative time, lower blood loss and shorter hospital stay. Lymph node yield was higher in LG. Conclusion: LG for AGC seems to provide satisfactory clinical and oncological outcomes in medium volume centers, improved postoperative results and possibly lower recurrence rates.
引用
收藏
页码:8442 / 8455
页数:14
相关论文
共 77 条
[1]   Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO): A multicenter, randomized phase 3 trial. [J].
Al-Batran, Salah-Eddin ;
Homann, Nils ;
Schmalenberg, Harald ;
Knopp, Hans-Georg ;
Georg .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[2]   Liquid biopsies and cancer omics [J].
Amelio, Ivano ;
Bertolo, Riccardo ;
Bove, Pierluigi ;
Buonomo, Oreste Claudio ;
Candi, Eleonora ;
Chiocchi, Marcello ;
Cipriani, Chiara ;
Di Daniele, Nicola ;
Ganini, Carlo ;
Juhl, Hartmut ;
Mauriello, Alessandro ;
Marani, Carla ;
Marshall, John ;
Montanaro, Manuela ;
Palmieri, Giampiero ;
Piacentini, Mauro ;
Sica, Giuseppe ;
Tesauro, Manfredi ;
Rovella, Valentina ;
Tisone, Giuseppe ;
Shi, Yufang ;
Wang, Ying ;
Melino, Gerry .
CELL DEATH DISCOVERY, 2020, 6 (01)
[3]   Laparoscopic Versus Open D2 Gastrectomy for Gastric Cancer: A Case-Matched Comparative Study [J].
Ammori, Basil J. ;
Asmer, Huthaifa ;
Al-Najjar, Hani ;
Al-Bakri, Hebah ;
Dabous, Ali ;
Daoud, Faiez ;
Almasri, Mahmoud .
JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES, 2020, 30 (07) :777-782
[4]   Early results of a randomized two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S-1 and docetaxel/cisplatin/S-1 as neoadjuvant chemotherapy for locally advanced gastric cancer [J].
Aoyama, T. ;
Nishikawa, K. ;
Fujitani, K. ;
Tanabe, K. ;
Ito, S. ;
Matsui, T. ;
Miki, A. ;
Nemoto, H. ;
Sakamaki, K. ;
Fukunaga, T. ;
Kimura, Y. ;
Hirabayashi, N. ;
Yoshikawa, T. .
ANNALS OF ONCOLOGY, 2017, 28 (08) :1876-1881
[5]   Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035 [J].
Arnold, Melina ;
Park, Jin Young ;
Camargo, M. Constanza ;
Lunet, Nuno ;
Forman, David ;
Soerjomataram, Isabelle .
GUT, 2020, 69 (05) :823-829
[6]   Minimally invasive surgery for gastric cancer [J].
Bamboat, Zubin M. ;
Strong, Vivian E. .
JOURNAL OF SURGICAL ONCOLOGY, 2013, 107 (03) :271-276
[7]   Feasibility and outcomes of ERAS protocol in elective cT4 colorectal cancer patients: results from a single-center retrospective cohort study [J].
Bellato, Vittoria ;
An, Yongbo ;
Cerbo, Daniele ;
Campanelli, Michela ;
Franceschilli, Marzia ;
Khanna, Krishn ;
Sensi, Bruno ;
Siragusa, Leandro ;
Rossi, Piero ;
Sica, Giuseppe S. .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
[8]   Laparoscopic versus open gastrectomy for gastric cancer [J].
Best, Lawrence M. J. ;
Mughal, Muntzer ;
Gurusamy, Kurinchi Selvan .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (03)
[9]   Lparoscopic versus open gastrectomy for locally advanced gastric cancer: a systematic review and meta-analysis of randomized controlled studies [J].
Beyer, Katharina ;
Baukloh, Ann-Kathrin ;
Kamphues, Carsten ;
Seeliger, Hendrik ;
Heidecke, Claus-Dieter ;
Kreis, Martin E. ;
Patrzyk, Maciej .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2019, 17
[10]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]